Deal watch: Bristol-Myers Squibb acquires potential keys to treating rheumatoid arthritis.

Nature reviews. Drug discovery

PubMedID: 27139990

Cully M. Deal watch: Bristol-Myers Squibb acquires potential keys to treating rheumatoid arthritis. Nat Rev Drug Discov. 2016;15(5):301.
An abstract is not available. Please access the article through the links below.